Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39598

DOCK5 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The DOCK5 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from HeLa cells, featuring disruption of the DOCK5 gene. DOCK5 encodes a Rac-specific GEF that, in complex with ELMO proteins, activates Rac1 signaling to promote actin polymerization, cell migration, and adhesion. This knockout model is useful for investigating signaling pathways regulating cell motility, cancer metastasis, and osteoclast differentiation, with applications in Transwell migration assays, Rac activity pull-downs, and immunofluorescence. Upstream regulators such as integrins and receptor tyrosine kinases converge on the DOCK5-ELMO-Rac1 axis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    DOCK5

    Gene Identifier

    NCBI Gene ID 80005

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DOCK5 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the DOCK5 gene in a HeLa host background. This gene-disrupted model provides a powerful tool for dissecting DOCK5-dependent signaling events that govern cytoskeletal organization, cell migration, and adhesion. The polyclonal format avoids selection bias inherent in single-cell cloning and maintains population-level heterogeneity, making it suitable for experiments requiring pooled knockout cells rather than clonal derivatives. Researchers can employ this resource to interrogate the functional significance of DOCK5 in Rac-mediated biological processes.

The parental HeLa cell line is an extensively characterized immortalized epithelial line isolated from a human cervical adenocarcinoma and is positive for human papillomavirus type 18 (HPV-18). These cells exhibit high transfection efficiency and well-mapped signaling networks, making them ideal for gene-editing approaches. Their adherent nature and widespread use in cell migration and adhesion studies offer a relevant context for investigating DOCK5, which plays a central role in actin cytoskeleton reorganization.

DOCK5 is a Rac-specific guanine nucleotide exchange factor (GEF) that, in complex with ELMO1 and ELMO2, catalyzes the exchange of GDP for GTP on Rac1, thereby activating downstream signaling. Upstream regulators such as integrins, receptor tyrosine kinases, chemokine receptors, and growth factors stimulate the DOCK5-ELMO complex. Activated Rac1 promotes actin polymerization via effectors including PAK kinases, the WAVE regulatory complex, and the Arp2/3 complex, while also engaging the JNK and p38 MAP kinase pathways. Interacting proteins like RhoG and Crk modulate DOCK5-ELMO assembly and activity, linking this module to other Rho-family GTPase networks.

Disrupting DOCK5 in HeLa cells impairs Rac-dependent lamellipodia formation, cell migration, and focal adhesion dynamics. Given the cervical adenocarcinoma origin of HeLa, this knockout model is particularly relevant for studying cancer invasion and metastasis. Moreover, DOCK5’s known role in osteoclast differentiation and bone resorption makes this system valuable for dissecting conserved Rac signaling modules that coordinate actin reorganization and adhesion turnover across cell types. The epithelial background also enables examination of DOCK5 function within cell-cell junctions and polarized migration.

This polyclonal knockout population supports a variety of downstream applications, including Transwell migration and invasion assays, Rac-GTP pull-downs, phospho-signaling analyses, and adhesion assays. Immunofluorescence microscopy can visualize changes in actin cytoskeletal structures and focal adhesions. For osteoclast-related research, co-culture or conditioned medium experiments can be performed. The cells are also suitable for genetic rescue experiments by re-expressing DOCK5 variants and for validating pharmacological inhibitors targeting the DOCK5-ELMO pathway. For further technical details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)